Central Adelaide Local Health Network Incorporated Report issue

Government Phase 1 Phase 2

Organization Overview

First Clinical Trial
2016
NCT03066986
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

CALHN | Central Adelaide Local Health Network Incorporated

Active Ingredients

Drugs in Phase 2 Trials (1)

delta-inulin (1 trial)

Drugs in Phase 1 Trials (2)

advax (1 trial)

covid19 recombinant spike protein (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Bites and Stings (Phase 2)

Coronavirus Infections (Phase 1)

Severe Acute Respiratory Syndrome (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 3